• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

An Experimental Study of Prevention of Atherosclerosis by Antisense Therapy for Scavenger Receptor with a Unique Nonvirus Vector

Research Project

Project/Area Number 10670221
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Experimental pathology
Research InstitutionFukuoka Univ.

Principal Investigator

JIMI Keijiro  Fukuoka Univ., School of Medicine, Assistant Professor, 医学部, 助手 (30226360)

Co-Investigator(Kenkyū-buntansha) TAKEBAYASHI Shigeo  Fukuoka Univ., School of Medicine, Professor, 医学部, 教授 (80078740)
OHTA Takao  Univ. of the Ryukyus, Fac.Med., Professor, 医学部, 教授 (70185271)
SAKU Keijiro  Fukuoka Univ., School of Medicine, Professor, 医学部, 教授 (40183371)
Project Period (FY) 1998 – 2000
KeywordsGene therapy / SR-BI / Atherosclerosis / Ppeptide vector / HDL / CETP
Research Abstract

We performed this project using a new gene delivery system with peptide of N,N-Dipalmitylglycyl-apolipoprotein E motif (129-169)(dpGapoE). First, we examined possibility of this gene delivery system in the lipid metabolism in vitro. Antisense treatment against human cholesteryl ester transfer protein (hCETP) was performed in hCETP transfected cell line. After transfection, translocation of antisense was detected in the cells, especially in the lysosome and the nucleus. Cellular CETP mRNA levels and its activity significantly declined. When LDL added to culture media of cultured cells before transfection with antisense and dpGapoE complex, reduction of transfection was noted. We conclude that, in vitro, dpGapoE effectively deliver antisense into cells through apoE receptor, and it can react with DNA to prevent protein transcription. We applied this method to organ culture and animal model. In liver organ culture, similar results were obtained. However, in animal model, when dpGapoE and … More antisense complex was administered via portal vein, most of them was trapped in the Kupffer cells and endothelial cells in the liver, while few hepatocytes near the portal area showed to be translocation. To examine possibility of gene therapy for prevention of atherosclerosis, we next adopted human CETP transgenic (CETP-Tg) mice, since they were characterized by decreased HDL-cholesterol (HDL-C) and increased LDL-cholesterol (LDL-C). We gave a cholesterol rich diet to CETP-Tg and wild mice. In cholesterol fed mice, plasma levels of total cholesterol and LDL-C increased, and were significantly greater in wild mice than CETP-Tg. After feeding with cholesterol, HDL-C was still lower in CETP-Tg than wild mice. The extent of lipid rich lesion in the aorta was positively correlated with plasma level of total cholesterol and LDL-C.Its area was, however, significantly smaller in CETP-Tg than wild mice. However, CETP-Tg had greater cholesterol contents in the liver and the feces. These results indicated that cholesterol excretion was quite active in CETP-Tg, represented that receptor mediated pathway, such as SR-BI, could be activated. It is, therefore, difficult to prevent HDL uptake in the liver of this animal to prevent atherosclerosis. Less

  • Research Products

    (29 results)

All Other

All Publications (29 results)

  • [Publications] Saku K.,Takeda Y.,Jimi S.,Okabe M.,Shirai K.,Nii T.,Naito S.,Arakawa K.: "Long-term effect of low-density lipoprotein apheresis in a patients with heterozygous familial hypercholesterolemia : follow-up study using coronary angiography."J Cardiology. 31. 239-245 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Jimi S.,Takebayashi S.,Ryu S.,Saku K.: "Higher migratory activity of arterial smooth muscle cells than of venous smooth muscle cells on different collagen matrices."Phlebology. 13. 120-125 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Itabe H.,Jimi S.,Kamimura S.,Suzuki K.,Uesugi N.,Imanaka T.,Shijo H.,Takano T.: "Appearance of cross linked proteins in human atheroma and rat pre-fibrotic liver detected by a new monoclonal antibody."Biochim Biophys Acta.. 1406. 28-39 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ou J.,Saku K.,Jimi S.,Ohta T.,Zhang B.,Pownall HJ.,Tsuita Y.,Arakawa K.: "Mechanism of action of probucol on cholesterol ester transfer protein (CETP) mRNA in a Chinese Hamster Ovary cell line that had been stably trensfected with a human CETP gene."Biochim Biophys Acta. 1393. 153-160 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Jimi S.,Saku K.,Kusaba H.,Itabe H.,Koga N.,Takebayashi S.: "Deposition of oxidized LDL and collagenosis occur coincidentally in human coronary stenosis : an immunohistochemical study of atherectomy."Coronary Artery Disease. 9. 551-557 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Saku K.,von Eckardstein A.,Zhang B.,Liu R.,Jimi S.,Ou JF.,Ohta T.Assmann G.,Arakawa K.: "In vivo kinetics of human apolipoprotein A-I variants in rabbits."Europ J Clin Invest. 29. 196-203 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Jimi S.,Uesugi N.,Saku K.,Itabe H.,Zhang B.,Arakawa K.,Takebayashi S.: "Possible induction of renal dysfunction in patients with lecithin : cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli."Arterioscle Thromb Vasc Biol. 19. 794-801 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ou J.,Saku K.,Jimi S.,Liao YL.,Ohta T.,Zhang B.,Arakawa K.: "Combine effects of probucol and bezafibrate on lipoprotein metabolism and liver cholesterol ester transfer protein mRNA in cholesterol-fed rabbits."Jpn Circ. J63. 471-477 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Liu K.,Ou J.,Saku K.,Jimi S.,Via DR.,Sparrow JT.,Zhang B.,Pownall HJ.,Smith LC.Arakawa K.: "Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apolipoprotein E peptide in a human CETP stably transfected CHO cell line."Arterioscle Thromb Vasc Biol. 19. 2207-2213 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Itabe H.,Hosoya R.,Karasawa K.,Jimi S.,Saku K.,Takebayashi S.,Imanaka T.,Takano T.: "Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase."J Biochem. 126. 153-161 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Liao YL.,Saku K.,Ou J.,Jimi S.,Zhang B.,Shirai K.,Arakawa K.: "A missense mutation of the nitric oxide synthese (eNOS) gene (Glu298Asp) in five patients with coronary artery disease. Case report."Angiology. 50. 671-676 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Saku K.,Zhang B.,Shirai K.,Jimi S.,Yoshinaga K.,Arakawa K.: "Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease."J Am Collage Cardiolo. 34. 1443-1445 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Saku K., Takeda Y., Jimi S., Okabe M., Shirai K., Nii T., Naito S., Arakawa K.: "Long-term effect of low-density lipoprotein apheresis in a patients with heterozygous familial hypercholesterolemia : follow-up study using coronary angiography."J Cardiology. 31. 239-245 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Jimi S., Takebayashi S., Ryu S., Saku K.: "Higher migratory activity of arterial smooth muscle cells than of venous smooth muscle cells on different collagen matrices."Phlebology. 13. 120-125 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Itabe H., Jimi S., Kamimura S., Suzuki K., Uesugi N., Imanaka T., Shijo H., Takano T.: "Appearance of cross linked proteins in human atheroma and rat prefibrotic liver detected by a new monoclonal antibody."Biochim Biophys Acta.. 1406. 28-39 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ou J., Saku K., Jimi S., Ohta T., Zhang B., Pownall HJ., Tsuita Y., Aradawa K.: "Mechanism of action of probucol on cholesterol ester transfer protein (CETP) mRNA in Chinese Hamster Ovary cell line that had been stably trensfected with a human CETP gene."Biochim Biophys Acta. 1393. 153-160 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Jimi S., Saku K., Kusaba H., Itabe H., Koga N., Takebayashi S.: "Deposition of oxidized LDL and collagenosis occur coincidentally in human coronary stenosis : an immunohistochemical study of atherectomy."Coronary Artery Disease. 9. 551-557 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saku K., von Eckardstein A., Zhang B., Liu R., Jimi S., Ou JF., Ohta T.Assmann G., Arakawa K.: "In vivo kinetics of human apoliporotein A-I variants in rabbits."Europ J Clin Invest. 29. 196-203 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Jimi S., Uesugi N., Saku K., Itabe H., Zhang B., Arakawa K., Takebayashi S.: "Possible induction of renal dysfunction in patients with lecithin : cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli"Arterioscle Thromb Vasc Biol. 19. 794-801 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takezako T., Saku K., Zhang B., Ou JF., Bai H., Imai K., Jimi S., Shirai K., Arakawa K.: "Angiotensin I Converting enzyme gene polymorphism and insulin resistence in patients with angina pectoris."Am J Hypertension. 12. 291-297 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ou J., Saku K., Jimi S., Liao YL., Ohta T., Zhang B., Arakawa K.: "Combine effects of probucol and bezafibrate on lipoprotein metabolism and liver cholesterol ester transfer protein mRNA in cholesterol-fed rabbits."Jpn Circ J. 63. 471-477 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Liu K., Ou J., Saku K., Jimi S., Via DR., Sparrow JT., Zhang B., Pownall HJ., Smith LC., Arakawa K.: "Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apolipoprotein E peptide in a human CETP stably transfected CHO cell line."Arterioscle Thromb Vasc Biol. 19. 2207-2213 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Itabe H., Hosoya R., Karasawa K., Jimi S., Saku K., Takebayashi S., Imanaka T., Takano T.: "Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase."J Biochem. 126. 153-161 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Liao YL., Saku K., Ou J., Jimi S., Zhang B., Shirai K., Arakawa K.: "A missense mutation of the nitric oxide synthese (eNOS) gene (Glu298Asp) in five patients with coronary artery disease. Case report."Angiology. 50. 671-676 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saku K., Zhang B., Shirai K., Jimi S., Yoshinaga K., Arakawa K.: "Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease."J Am Collage Cardiolo. 34. 1443-1445 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ou J., Saku K., Liao YL., Jimi S., Shirai K., Zhang B., Tashiro E., Arakawa K.: "Interaction of missense Glu298Asp mutation of the endothelial nitric oxide synthesis gene and angiotensin converting enzyme gen I/D polymorphism in patients with non-diabetic coronary artery disease."

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Saku K., Jimi S., Takebayashi S., Arakawa K.: "Lipoprotein (a) and atherosclerosis in patients with hemodialysis."Atherosclerosis in patients with hemodialysis (ed. by Yukawa S.and Nishizawa Y.) pp 110-113, Nihonn Igaku Shuppann, Tokyo (Japanese). (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Jimi S., Saku., Kusaba H., Takebayashi S.: "Lipoprotein (a) and atherosclerosis-coronary artery."Lipoprotein (a), Basic and clinical (ed by Hata M.) pp 180-188, Kyodo-Kikaku Co. Ltd (Tokyo). (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Jimi S., Takebayashi S.: "Blood Vessel and Endothelium 10 : 4, Series for morphology of blood vessel, part 52"Remodeling of the vain (ed by Maruyama I) pp386-389, Medical Tribune (Tokyo). (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi